Origami Therapeutics, Inc.
https://origamitherapeutics.comOral drugs to halt neurodegeneration
Origami Therapeutics, Inc. is a biotech company developing novel protein degraders with potential to delay or halt disease progression by eliminating toxic proteins from the body. Our drug discovery platform leverages our proprietary human disease models developed to select the small molecules with the best chance of clinical success. Our first indication is Huntington’s disease, a debilitating, progressive and ultimately fatal disorder caused by a genetic mutation. We have already identified small molecules that reduce the toxic mutated protein, suppress mutant protein-induced toxicities in human disease neurons and get into the brain. We anticipate that this approach will be broadly applicable to traditionally “undruggable” targets in other neurological diseases.
Total Open and Closed Positions
Total open positions, and positions newly closed since the previous update
Department Headcount Over Time
Open positions per department · top 6 at any point in the window
Newly Opened and Closed Positions
Position Churn Rate
Positions closed within 14 days of opening · a high rate suggests posting instability — duplicates, pulled listings, or roles filled through internal or off-market channels
Time-to-Fill Distribution
Days from open to close · closed positions only
Salary Trend Over Time
Monthly median base salary · USD · annualized · p25/p75 dashed
Salary Range by Department
Employment Type
Technical vs. Non-technical
Open positions · by department
Top Roles by Department
Seniority Mix
Derived from job title keywords
Equity Range by Department
Top Skills
Top Tech Stacks
Skills Trend
Change in share of postings · recent 3 months vs. prior 3 months
Tech Stack Evolution
Positions opened per month · top 5 technologies